220 related articles for article (PubMed ID: 34162850)
21. CRISPR-Cas3 induces broad and unidirectional genome editing in human cells.
Morisaka H; Yoshimi K; Okuzaki Y; Gee P; Kunihiro Y; Sonpho E; Xu H; Sasakawa N; Naito Y; Nakada S; Yamamoto T; Sano S; Hotta A; Takeda J; Mashimo T
Nat Commun; 2019 Dec; 10(1):5302. PubMed ID: 31811138
[TBL] [Abstract][Full Text] [Related]
22. Retroviral Vectors for Cancer Gene Therapy.
Schambach A; Morgan M
Recent Results Cancer Res; 2016; 209():17-35. PubMed ID: 28101685
[TBL] [Abstract][Full Text] [Related]
23. Discovering the Genome-Wide Activity of CRISPR-Cas Nucleases.
Tsai SQ
ACS Chem Biol; 2018 Feb; 13(2):305-308. PubMed ID: 29281250
[TBL] [Abstract][Full Text] [Related]
24. Implementing CRISPR-Cas12a for Efficient Genome Editing in Yarrowia lipolytica.
Yang Z; Xu P
Methods Mol Biol; 2021; 2307():111-121. PubMed ID: 33847985
[TBL] [Abstract][Full Text] [Related]
25. Cas12a variants designed for lower genome-wide off-target effect through stringent PAM recognition.
Zhou J; Chen P; Wang H; Liu H; Li Y; Zhang Y; Wu Y; Paek C; Sun Z; Lei J; Yin L
Mol Ther; 2022 Jan; 30(1):244-255. PubMed ID: 34687846
[TBL] [Abstract][Full Text] [Related]
26. A CRISPR-Cpf1 system for efficient genome editing and transcriptional repression in plants.
Tang X; Lowder LG; Zhang T; Malzahn AA; Zheng X; Voytas DF; Zhong Z; Chen Y; Ren Q; Li Q; Kirkland ER; Zhang Y; Qi Y
Nat Plants; 2017 Feb; 3():17018. PubMed ID: 28211909
[TBL] [Abstract][Full Text] [Related]
27. Efficient target cleavage by Type V Cas12a effectors programmed with split CRISPR RNA.
Shebanova R; Nikitchina N; Shebanov N; Mekler V; Kuznedelov K; Ulashchik E; Vasilev R; Sharko O; Shmanai V; Tarassov I; Severinov K; Entelis N; Mazunin I
Nucleic Acids Res; 2022 Jan; 50(2):1162-1173. PubMed ID: 34951459
[TBL] [Abstract][Full Text] [Related]
28. Targeted Modification of Mammalian DNA by a Novel Type V Cas12a Endonuclease from
Vasilev R; Gunitseva N; Shebanova R; Korzhenkov A; Vlaskina A; Evteeva M; Polushkina I; Nikitchina N; Toshchakov S; Kamenski P; Patrushev M; Mazunin I
Int J Mol Sci; 2022 Aug; 23(16):. PubMed ID: 36012553
[TBL] [Abstract][Full Text] [Related]
29. Optimized metrics for orthogonal combinatorial CRISPR screens.
Cetin R; Wegner M; Luwisch L; Saud S; Achmedov T; Süsser S; Vera-Guapi A; Müller K; Matthess Y; Quandt E; Schaubeck S; Beisel CL; Kaulich M
Sci Rep; 2023 May; 13(1):7405. PubMed ID: 37149686
[TBL] [Abstract][Full Text] [Related]
30. Structure and genome editing of type I-B CRISPR-Cas.
Lu M; Yu C; Zhang Y; Ju W; Ye Z; Hua C; Mao J; Hu C; Yang Z; Xiao Y
Nat Commun; 2024 May; 15(1):4126. PubMed ID: 38750051
[TBL] [Abstract][Full Text] [Related]
31. Targeted genome modification of crop plants using a CRISPR-Cas system.
Shan Q; Wang Y; Li J; Zhang Y; Chen K; Liang Z; Zhang K; Liu J; Xi JJ; Qiu JL; Gao C
Nat Biotechnol; 2013 Aug; 31(8):686-8. PubMed ID: 23929338
[No Abstract] [Full Text] [Related]
32. Repurposing type I-F CRISPR-Cas system as a transcriptional activation tool in human cells.
Chen Y; Liu J; Zhi S; Zheng Q; Ma W; Huang J; Liu Y; Liu D; Liang P; Songyang Z
Nat Commun; 2020 Jun; 11(1):3136. PubMed ID: 32561716
[TBL] [Abstract][Full Text] [Related]
33. A 'new lease of life': FnCpf1 possesses DNA cleavage activity for genome editing in human cells.
Tu M; Lin L; Cheng Y; He X; Sun H; Xie H; Fu J; Liu C; Li J; Chen D; Xi H; Xue D; Liu Q; Zhao J; Gao C; Song Z; Qu J; Gu F
Nucleic Acids Res; 2017 Nov; 45(19):11295-11304. PubMed ID: 28977650
[TBL] [Abstract][Full Text] [Related]
34. Optimizing ErCas12a for efficient gene editing in Arabidopsis thaliana.
Pietralla J; Capdeville N; Schindele P; Puchta H
Plant Biotechnol J; 2024 Feb; 22(2):401-412. PubMed ID: 37864303
[TBL] [Abstract][Full Text] [Related]
35. Engineered CRISPR-Cas9 nuclease with expanded targeting space.
Nishimasu H; Shi X; Ishiguro S; Gao L; Hirano S; Okazaki S; Noda T; Abudayyeh OO; Gootenberg JS; Mori H; Oura S; Holmes B; Tanaka M; Seki M; Hirano H; Aburatani H; Ishitani R; Ikawa M; Yachie N; Zhang F; Nureki O
Science; 2018 Sep; 361(6408):1259-1262. PubMed ID: 30166441
[TBL] [Abstract][Full Text] [Related]
36. Highly Efficient Genome Editing in Plant Protoplasts by Ribonucleoprotein Delivery of CRISPR-Cas12a Nucleases.
Zhang Y; Cheng Y; Fang H; Roberts N; Zhang L; Vakulskas CA; Niedz RP; Culver JN; Qi Y
Front Genome Ed; 2022; 4():780238. PubMed ID: 35174354
[TBL] [Abstract][Full Text] [Related]
37. Cas9, Cpf1 and C2c1/2/3-What's next?
Nakade S; Yamamoto T; Sakuma T
Bioengineered; 2017 May; 8(3):265-273. PubMed ID: 28140746
[TBL] [Abstract][Full Text] [Related]
38. Efficient Gene Editing of Human Induced Pluripotent Stem Cells Using CRISPR/Cas9.
Yumlu S; Bashir S; Stumm J; Kühn R
Methods Mol Biol; 2019; 1961():137-151. PubMed ID: 30912045
[TBL] [Abstract][Full Text] [Related]
39. CRISPR/Cpf1-mediated DNA-free plant genome editing.
Kim H; Kim ST; Ryu J; Kang BC; Kim JS; Kim SG
Nat Commun; 2017 Feb; 8():14406. PubMed ID: 28205546
[TBL] [Abstract][Full Text] [Related]
40. Highly efficient genome editing via CRISPR-Cas9 in human pluripotent stem cells is achieved by transient BCL-XL overexpression.
Li XL; Li GH; Fu J; Fu YW; Zhang L; Chen W; Arakaki C; Zhang JP; Wen W; Zhao M; Chen WV; Botimer GD; Baylink D; Aranda L; Choi H; Bechar R; Talbot P; Sun CK; Cheng T; Zhang XB
Nucleic Acids Res; 2018 Nov; 46(19):10195-10215. PubMed ID: 30239926
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
